386 related articles for article (PubMed ID: 16194137)
1. The 7th Amendment to the Cosmetics Directive.
Ruet Rossignol M
Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
[No Abstract] [Full Text] [Related]
2. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
3. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
4. The Seventh Amendment directive--an unnecessary measure to a necessary end--possible legal challenges to directive 2003/15/EC of the European Parliament and of the Council Amending Council Directive 76/768/EEC under European Union law.
Rosholt AP
Food Drug Law J; 2005; 60(3):421-46. PubMed ID: 16304747
[No Abstract] [Full Text] [Related]
5. Safety data requirements for the purposes of the Cosmetics Directive.
Manou I; Eskes C; de Silva O; Renner G; Zuang V
Altern Lab Anim; 2005 Jul; 33 Suppl 1():21-6. PubMed ID: 16194138
[No Abstract] [Full Text] [Related]
6. Reproductive and developmental toxicity.
Bremer S; Cortvrindt R; Daston G; Eletti B; Mantovani A; Maranghi F; Pelkonen O; Ruhdel I; Spielmann H
Altern Lab Anim; 2005 Jul; 33 Suppl 1():183-209. PubMed ID: 16194149
[No Abstract] [Full Text] [Related]
7. Eye irritation.
Eskes C; Bessou S; Bruner L; Curren R; Harbell J; Jones P; Kreiling R; Liebsch M; McNamee P; Pape W; Prinsen MK; Seidle T; Vanparys P; Worth A; Zuang V
Altern Lab Anim; 2005 Jul; 33 Suppl 1():47-81. PubMed ID: 16194141
[No Abstract] [Full Text] [Related]
8. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
9. The seventh amendment to the cosmetics directive: what does DG enterprise want from ECVAM?
Schumann R
Altern Lab Anim; 2002 Dec; 30 Suppl 2():213-4. PubMed ID: 12513678
[TBL] [Abstract][Full Text] [Related]
10. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
11. Subacute and subchronic toxicity.
Prieto P; Clemedson C; Meneguz A; Pfaller W; Sauer UG; Westmoreland C
Altern Lab Anim; 2005 Jul; 33 Suppl 1():109-16. PubMed ID: 16194144
[No Abstract] [Full Text] [Related]
12. Cosmetic products and their current European regulatory framework.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
[No Abstract] [Full Text] [Related]
13. Genotoxicty and mutagenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():117-30. PubMed ID: 16194145
[No Abstract] [Full Text] [Related]
14. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Prentice D; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():177-82. PubMed ID: 16194148
[No Abstract] [Full Text] [Related]
16. Skin irritation and corrosion.
Zuang V; Alonso MA; Botham PA; Eskes C; Fentem J; Liebsch M; van de Sandt JJ
Altern Lab Anim; 2005 Jul; 33 Suppl 1():35-46. PubMed ID: 16194140
[No Abstract] [Full Text] [Related]
17. Developing alternatives to systemic toxicity testing approaches.
von Aulock S
ALTEX; 2012; 29(1):1. PubMed ID: 22408846
[No Abstract] [Full Text] [Related]
18. Acute toxicity.
Gribaldo L; Gennari A; Blackburn K; Clemedson C; Deguercy A; Meneguz A; Pfaller W; Ruhdel I
Altern Lab Anim; 2005 Jul; 33 Suppl 1():27-34. PubMed ID: 16194139
[No Abstract] [Full Text] [Related]
19. Skin sensitisation.
Basketter D; Casati S; Gerberick GF; Griem P; Philips B; Worth A
Altern Lab Anim; 2005 Jul; 33 Suppl 1():83-103. PubMed ID: 16194142
[No Abstract] [Full Text] [Related]
20. Challenges related to cosmetic safety assessment in the EU.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
